Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8647879rdf:typepubmed:Citationlld:pubmed
pubmed-article:8647879lifeskim:mentionsumls-concept:C0033164lld:lifeskim
pubmed-article:8647879lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:8647879lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:8647879lifeskim:mentionsumls-concept:C0009221lld:lifeskim
pubmed-article:8647879lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8647879lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:8647879pubmed:issue21lld:pubmed
pubmed-article:8647879pubmed:dateCreated1996-7-22lld:pubmed
pubmed-article:8647879pubmed:abstractTextPrion diseases are thought to be caused by the conversion of the normal, or cellular, prion protein (PrPC)(PrPres). There are three familial forms of human prion disease, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker syndrome, and fatal familial insomnia (FFI) which are all expressed at advanced age despite the congenital presence of the mutant prion protein (PrPM). The cellular mechanisms that result in the age-dependent conversion of PrPM into PrPres and the unique phenotypes associated with each PrPM are unknown. FFI and a familial type of Creutzfeldt-Jakob disease (CJD178), share the D178N mutation in the PrP gene but have distinct phenotypes linked to codon 129, the site of a methionine/valine polymorphism (129M/V). We analyzed PrP processing in cells transfected with constructs reproducing the FFI and CJD178 genotypes. The D178N mutation results in instability of the mutant PrP which is partially corrected by N-glycosylation. Hence, only the glycosylated forms of PrPM reach the cell surface whereas the unglycosylated PrPM is also under-represented in the brain of FFI patients validating the cell model. These results offer new insight into the effect of the D178N mutation on the metabolism of the prion protein.lld:pubmed
pubmed-article:8647879pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8647879pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8647879pubmed:languageenglld:pubmed
pubmed-article:8647879pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8647879pubmed:citationSubsetIMlld:pubmed
pubmed-article:8647879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8647879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8647879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8647879pubmed:statusMEDLINElld:pubmed
pubmed-article:8647879pubmed:monthMaylld:pubmed
pubmed-article:8647879pubmed:issn0021-9258lld:pubmed
pubmed-article:8647879pubmed:authorpubmed-author:GambettiPPlld:pubmed
pubmed-article:8647879pubmed:authorpubmed-author:RichardsonS...lld:pubmed
pubmed-article:8647879pubmed:authorpubmed-author:ParchiPPlld:pubmed
pubmed-article:8647879pubmed:authorpubmed-author:PetersenR BRBlld:pubmed
pubmed-article:8647879pubmed:authorpubmed-author:UrigC BCBlld:pubmed
pubmed-article:8647879pubmed:issnTypePrintlld:pubmed
pubmed-article:8647879pubmed:day24lld:pubmed
pubmed-article:8647879pubmed:volume271lld:pubmed
pubmed-article:8647879pubmed:ownerNLMlld:pubmed
pubmed-article:8647879pubmed:authorsCompleteYlld:pubmed
pubmed-article:8647879pubmed:pagination12661-8lld:pubmed
pubmed-article:8647879pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:meshHeadingpubmed-meshheading:8647879-...lld:pubmed
pubmed-article:8647879pubmed:year1996lld:pubmed
pubmed-article:8647879pubmed:articleTitleEffect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein.lld:pubmed
pubmed-article:8647879pubmed:affiliationDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. rbp@po.cwru.edulld:pubmed
pubmed-article:8647879pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8647879pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8647879pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8647879lld:pubmed